Showing 16-20 of 34 :
Real-World Data and External Control Arms 101

Thu, Apr 29, 2021 11:30 AM – 12:30 PM EDT Register Real-world data is increasingly being used to develop external control arms for trial planning and regulatory submissions. Understanding the basics of what they are and how they can be used effectively are critical to success. Join Dr. Richard Gliklich, CEO of OM1, as he[…]

Putting Real-World Data & AI to Work for Rare Diseases

Thu, Feb 25, 2021 11:00 AM – 12:00 PM EST Register Accessibility to real-world data (RWD) and advances in artificial intelligence (AI) driven models and technologies make a powerful combination in advancing research and development efforts. So how do we use these new tools to tackle the challenges in developing and launching new treatments for[…]

Analysis of Real-Word Data in Cardiovascular Disease: Missing Data and Predictive Modeling

Tues. January 26, 2021 2:00-3:00 PM Register Real-world data (RWD) is playing an increasing role in health care decisions, especially with cardiovascular conditions such as heart failure where risk of mortality is high and comorbidities, varying symptom presentation, and disease progression drastically determine treatment pathways and outcomes. Join OM1’s Chief Medical Officer Dr. Gary Curhan[…]

RWD for R&D and Market Access in Autoimmune and Chronic Diseases

Thu. Nov. 19, 2020 1:00 PM – 2:00 PM Register From accelerating clinical trials and gaining regulatory approval to expanding access and understanding market needs, this webinar will cover the basics of what makes real-world data regulatory and research grade and how it can transform your R&D and market access programs for autoimmune and other[…]